Tatva Chintan Pharma Chem Limited cancelled its scheduled earnings call for the quarter and half-year ended September 30, 2026. The conference call was originally set for October 19, 2026, at 5:00 pm IST.

The cancellation was communicated to stock exchanges on October 19, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company cited unforeseen circumstances as the reason for withdrawing the scheduled interaction with investors and analysts.

Regulatory Disclosure

The intimation was filed with both BSE Limited and National Stock Exchange of India Limited. It referenced an earlier disclosure dated October 13, 2026, which had confirmed the earnings call would follow the announcement of financial results for Q2FY27.

Company Statement

In its filing, the company expressed regret for any inconvenience caused by the cancellation. The information regarding the cancellation is available on the company's official website. No further details regarding a rescheduled date were provided in the immediate notification.

Tatva Chintan Pharma Chem Limited shareholders approved the re-appointment of Chairman and Managing Director Chintan Nitinkumar Shah and Whole-time Directors Shekhar Rasiklal Somani and Ajaykumar Mansukhlal Patel at the 30th Annual General Meeting (AGM) held on September 25, 2026.

The meeting, conducted via Video Conferencing (VC), also ratified the borrowing limits and creation of charges on assets. The resolutions were passed through e-voting, with results to be disseminated by the scrutinizer, M/s. TNT & Associates.

Director re-appointments approved

Shareholders voted to retain the core leadership team for a three-year term effective February 1, 2027. The special business items included:

Mr. Somani was also re-appointed as a Director retiring by rotation under ordinary business. The remuneration for these roles was fixed as part of the same resolutions.

Financial and operational approvals

The AGM adopted the audited standalone and consolidated financial statements for FY26. Members also approved the declaration of dividend on equity shares for the fiscal year ended March 31, 2026. Specific operational approvals included:

• Increase in borrowing limit under Section 180(1)(c) of the Companies Act, 2013.
• Creation of charges on company assets under Section 180(1)(a).
• Ratification of cost auditor remuneration for FY27.

Meeting proceedings

The meeting commenced at 4:00 pm and concluded at 4:53 pm. A quorum was met with 56 members attending through VC/OAVM. Key managerial personnel present included CFO Ajesh Pillai and Company Secretary Ishwar Nayi. Statutory auditor M/s. NDJ & Co. and secretarial auditor M/s. TNT & Associates were also in attendance. The Board’s report and statutory audit reports were taken as read, with no questions raised during the session.